Market Access Sponsored NCVR: What's the true price of negotiation? A country’s ability to open trials quickly is a key consideration for commercial sponsors planning programmes of research globally.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face